Effects of the 5-HT6 receptor antagonists SB-399885 and RO-4368554 and of the 5-HT2A receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light

Effects of the 5-HT6 receptor antagonists SB-399885 and RO-4368554 and of the 5-HT2A receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light–dark cycle

Published:2011-01 Issue:1 Volume:216 Page:381-388
ISSN:0166-4328
Container-title:Behavioural Brain Research
language:en
Short-container-title:Behavioural Brain Research

Author:

Monti Jaime M.,Jantos Héctor

Publisher

Elsevier BV

Subject

Behavioral Neuroscience

Reference38 articles.

1. Effects of the selective 5-HT1B agonist. CGS 12066B, on sleep/waking stages and EEG power spectrum in rats;Bjorvatn;J Sleep Res,1994

2. Key role of 5-HT1B receptors in the regulation of paradoxical sleep as evidenced in 5-HT1B knock-out mice;Boutrel;Neuroscience,1999

3. The biochemical basis of neuropharmacology;Cooper,1990

4. In vivo effects of the 5-HT6 antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate;Dawson;Br J Pharmacol,2000

5. The 5-HT6 antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus;Dawson;Neuropsychopharmacology,2001

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dorsal raphe nucleus to basolateral amygdala 5-HTergic neural circuit modulates restoration of consciousness during sevoflurane anesthesia;Biomedicine & Pharmacotherapy;2024-07

2. Central nucleus of the amygdala to medial prefrontal cortex 5-HTergic neural circuit modulates the recovery of consciousness during sevoflurane anesthesia;2024-06-23

3. Herbal medicines for insomnia through regulating 5-hydroxytryptamine receptors: a systematic review;Chinese Journal of Natural Medicines;2023-07

4. The role of monoaminergic neurons in modulating respiration during sleep and the connection with SUDEP;Biomedicine & Pharmacotherapy;2022-06

5. Central Nervous System (CNS) Safety Pharmacology Studies;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2022